Interaction between tramadol and two anti-emetics on nociception and gastrointestinal transit in mice

European Journal of Pain

Volumn 10, Issue 7, 2006, Pages 629-

  Dürsteler, Christian ^a   Mases, Anna ^a   Fernandez, Victor ^a   Pol, Olga ^a   Puig, Margarita M ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

5 HT antagonists; Analgesics opioid; Droperidol; Isoboles; Pain experimental

Indexed keywords

ACETIC ACID; ANTIEMETIC AGENT; CHARCOAL; DROPERIDOL; ONDANSETRON; TRAMADOL;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; FEMALE; GASTROINTESTINAL TRANSIT; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; TEST MEAL; THERMAL STIMULATION; WITHDRAWAL REFLEX; WRITHING TEST;

EID: 33747767673     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2005.10.002     Document Type: Article

References (34)

1. Apfel C.C., Laara E., Koivuranta M., Greim C.A., and Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 91 (1999) 693-700
2. Arcioni R., della Rocca M., Romano S., Romano R., Pietropaoli P., and Gasparetto A. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT (3) spinal receptor involvement in acute pain in humans. Anesth Analg 94 (2002) 1553-1557
3. Berenbaum M.C. What is synergy?. Pharmacol Rev 41 (1989) 93-141
4. Caudle R.M., and Williams G.M. The misuse of analysis of variance to detect synergy in combination drug studies. Pain 55 (1993) 313-317
5. Collier H.O., Dinneen L.C., Johnson C.A., and Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32 (1968) 295-310
6. Dayer P., Desmeules J., and Collart L. Pharmacology of tramadol. Drugs 53 Suppl 2 (1997) 18-24
7. De Witte J.L., Schoenmaekers B., Sessler D.I., and Deloof T. The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. Anesth Analg 92 (2001) 1319-1321
8. Deegan R. Ondansetron: pharmacology of a specific 5-HT3-receptor antagonist. Am J Med Sci 304 (1992) 373-378
9. Driessen B., Reimann W., and Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 108 (1993) 806-811
10. Duman E.N., Kesim M., Kadioglu M., Yaris E., Kalyoncu N.I., and Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci 94 (2004) 161-165
11. Frink M.C., Hennies H.H., Englberger W., Haurand M., and Wilffert B. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 46 (1996) 1029-1036
12. Habib A.S., and Gan T.J. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 96 (2003) 1377-1379
13. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
14. Henzi I., Sonderegger J., and Tramer M.R. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 47 (2000) 537-551
15. Macario A., Weinger M., Carney S., and Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 89 (1999) 652-658
16. McCleane G.J., Suzuki R., and Dickenson A.H. Does a single intravenous injection of the 5-HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth Analg 97 (2003) 1474-1478
17. Miaskowski C., Sutters K.A., Taiwo Y.O., and Levine J.D. Antinociceptive and motor effects of δ/μ and κ/μ combinations of intrathecal opioid agonists. Pain 49 (1992) 137-144
18. Millan M.J. Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain 58 (1994) 45-61
19. Oatway M.A., Chen Y., and Weaver L.C. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 110 (2004) 259-268
20. Petersen-Felix S., Arendt-Nielsen L., Bak P., Bjerring P., Breivik H., Svensson P., et al. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 73 (1994) 326-330
21. Planas E., Poveda R., Sanchez S., Romero A., and Puig M.M. Non-steroidal anti-inflammatory drugs antagonise the constipating effects of tramadol. Eur J Pharmacol 482 (2003) 223-226
22. Poveda R., Planas E., Pol O., Romero A., Sanchez S., and Puig M.M. Interaction between metamizol and tramadol in a model of acute visceral pain in rats. Eur J Pain 7 (2003) 439-448
23. Puig M.M., Pol O., and Warner W. Interaction of morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 85 (1996) 1403-1412
24. Puig M.M., Warner W., and Pol O. Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 93 (2000) 219-230
25. Rodgers R.J., Shepherd J.K., and Randall J.I. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice. Neuropharmacology 29 (1990) 17-23
26. Sandrini M., Pini L.A., and Vitale G. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm Res 52 (2003) 347-352
27. Sarlani E., Grace E.G., Reynolds M.A., and Greenspan J.D. Sex differences in temporal summation of pain and aftersensations following repetitive noxious mechanical stimulation. Pain 109 (2004) 115-123
28. Scuderi P.E., and Conlay L.A. Postoperative nausea and vomiting and outcome. Int Anesthesiol Clin 41 (2003) 165-174
29. Statile L., Puig M.M., Warner W., Bansinath M., Lovitz M., and Turndorf H. Droperidol enhances fentanyl and sufentanil, but not morphine, analgesia. Gen Pharmacol 19 (1988) 451-454
30. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain 49 (1992) 93-97
31. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis (2000), Chapman & Hall and CRC
32. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs (1986), Springer-Verlag
33. Taylor B.K., Joshi C., and Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987 (2003) 135-143
34. Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol Suppl 113 (2000) 37-45